参考文献/References:
[1] Wong IY,Bhatia SN,Toner M.Nanotechnology:emerging tools for biology and medicine[J].Genes Dev,2013,27(22):2397-2408.
[2] Karimi M,Zare H,Bakhshian NA,et al.Nanotechnology in diagnosis and treatment of coronary artery disease[J].Nanomedicine(Lond),2016,11(5):513-530.
[3] Ambesh P,Campia U,Obiagwu C,et al.Nanomedicine in coronary artery disease[J].Indian Heart J,2017,69(2):244-251.
[4] Peters D,Kastantin M,Kotamraju V,et al.Targeting atherosclerosis by using modular,multifunctional micelles[J].Proc Natl Acad Sci U S A,2009,106(24):9815-9819.
[5] Cyrus T,Wickline SA,Lanza GM.Nanotechnology in interventional cardiology[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2012,4(1): 82-95.
[6] Tsukie N,Nakano K,Matoba T,et al.Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model[J].J Atheroscler Thromb,2013,20(1):32-45.
[7] Madhurantakam S,Babu KJ,Rayappan JBB,et al.Nanotechnology-based electrochemical detection strategies for hypertension markers[J].Biosens Bioelectron,2018,116:67-80.
[8] Sun B,Gou Y,Ma Y,et al.Investigate electrochemical immunosensor of cortisol based on gold nanoparticles/magnetic functionalized reduced graphene oxide[J].Biosens Bioelectron,2017,88:55-62.
[9] Alam T,Khan S,Gaba B,et al.Nanocarriers as treatment modalities for hypertension[J].Drug Deliv,2017,24(1):358-369.
[10] Cabrales P,Han G,Roche C,et al.Sustained release nitric oxide from long-lived circulating nanoparticles[J].Free Radic Biol Med,2010,49(4):530-538.
[11] Sharma M,Sharma R,Jain DK.Nanotechnology based approaches for enhancing oral bioavailability of poorly water soluble antihypertensive drugs[J].Scientifica(Cairo),2016,2016:8525679.
[12] Nakamura K,Matsubara H,Akagi S,et al.Nanoparticle-mediated drug delivery system for pulmonary arterial hypertension[J].J Clin Med,2017,6(5):48.
[13] Ghasemian E,Motaghian P,Vatanara A.D-optimal design for preparation and optimization of fast dissolving bosentan nanosuspension[J].Adv Pharm Bull,2016,6(2):211-218.
[14] Akagi S,Nakamura K,Matsubara H,et al.Intratracheal administration of prostacyclin analogue-incorporated nanoparticles ameliorates the development of monocrotaline and sugen-hypoxia-induced pulmonary arterial hypertension[J].J Cardiovasc Pharmacol,2016,67(4):290-298.
[15] Akagi S,Nakamura K,Miura D,et al.Delivery of imatinib-incorporated nanoparticles into lungs suppresses the development of monocrotaline-induced pulmonary arterial hypertension[J].Int Heart J,2015,56(3):354-359.
[16] Yongjun Q,Huanzhang S,Wenxia Z,et al.From changes in local RAAS to structural remodeling of the left atrium:a beautiful cycle in atrial fibrillation[J]. Herz,2015,40(3):514-520.
[17] Lu Z,Scherlag BJ,Lin J,et al.Autonomic mechanism for initiation of rapid firing from atria and pulmonary veins:evidence by ablation of ganglionated plexi[J].Cardiovasc Res,2009,84(2):245-252.
[18] Yu L,Scherlag BJ,Dormer K,et al.Autonomic denervation with magnetic nanoparticles[J].Circulation,2010,122(25):2653-2659.
[19] Madigan M,Atoui R.Therapeutic use of stem cells for myocardial infarction[J].Bioengineering(Basel),2018,5(2):28.
[20] Zhu K,Li J,Wang Y,et al.Nanoparticles-assisted stem cell therapy for ischemic heart disease[J].Stem Cells Int,2016,2016:1384658.
[21] Binsalamah ZM,Paul A,Khan AA,et al.Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model[J].Int J Nanomedicine,2011,6:2667-2678.
[22] Nakano Y,Matoba T,Tokutome M,et al.Nanoparticle-mediated delivery of irbesartan induces cardioprotection from myocardial ischemia-reperfusion injury by antagonizing monocyte-mediated inflammation[J].Sci Rep,2016,6:29601.
[23] Galagudza M,Korolev D,Postnov V,et al.Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles[J]. Int J Nanomedicine,2012,7:1671-1678.
[24] Torchilin VP.Multifunctional,stimuli-sensitive nanoparticulate systems for drug delivery[J].Nat Rev Drug Discov,2014,13(11):813-827.
[25] Chaudhary MA,Guo LW,Shi X,et al.Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery[J].J Control Release,2016,233:174-180.
[26] Amezcua R,Shirolkar A,Fraze C,et al.Nanomaterials for cardiac myocyte tissue engineering[J].Nanomaterials(Basel),2016,6(7):133.
[27] Kim DH,Kim P,Song I,et al.Guided three-dimensional growth of functional cardiomyocytes on polyethylene glycol nanostructures[J].Langmuir,2006,22(12):5419-5426.
[28] Malki M,Fleischer S,Shapira A,et al.Gold nanorod-based engineered cardiac patch for suture-free engraftment by near IR[J]. Nano Lett,2018,18(7): 4069-4073.
[29] Singelyn J,DeQuach J,Seif-Naraghi S,et al.Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering[J]. Biomaterials,2009,30(29):5409-5416.
[30] Hernandez MJ,Christman KL.Designing acellular injectable biomaterial therapeutics for treating myocardial infarction and peripheral artery disease[J].JACC Basic Transl Sci,2017,2(2):212-226.
[31] Evans B,Hocking K,Osgood M,et al.MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia[J].Sci Transl Med,2015,7(291):291ra295.
[32] Li H,Chai S,Dai L,et al.Collagen external scaffolds mitigate intimal hyperplasia and improve remodeling of vein grafts in a rabbit arteriovenous graft model[J].Biomed Res Int,2017,2017:7473437.
[33] Robinson E,Kaushal S,Alaboson J,et al.Combinatorial release of dexamethasone and amiodarone from a nano-structured parylene-C film to reduce perioperative inflammation and atrial fibrillation[J]. Nanoscale,2016, 8(7):4267-4275.
[34] Burkhardt J,Natale A.New technologies in atrial fibrillation ablation[J]. Circulation,2009,120(15):1533-1541.
[35] DaCosta A,Guichard J,Maillard N,et al.Substantial superiority of Niobe ES over NiobeⅡsystem in remote-controlled magnetic pulmonary vein isolation[J]. Int J Cardiol,2017,230:319-323.
[36] Qian P,DeSilva K,Kumar S,et al.Early and long-term outcomes after manual and remote magnetic navigation-guided catheter ablation for ventricular tachycardia[J].Europace,2018,20(suppl 2):ii11-ii21.
[37] Grodanz E.Robotic mitral valve repair[J].J Cardiovasc Nurs,2015,30(4): 325-331.
[38] Smitson C,Ang L,Pourdjabbar A,et al.Safety and feasibility of a novel,second-generation robotic-assisted system for percutaneous coronary intervention:first-in-human report[J].J Invasive Cardiol,2018,30(4):152-156.
[39] Khalpey Z,Korovin L,Chitwood W,et al.Robot-assisted septal myectomy for hypertrophic cardiomyopathy with left ventricular outflow tract obstruction[J].J Thorac Cardiovasc Surg,2014,147(5):1708-1709.
[40] Tuna E,Franke T,Bebek O,et al.Heart motion prediction based on adaptive estimation algorithms for robotic assisted beating heart surgery[J].IEEE Trans Robot,2013,29(1):261-276.